Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

NSE : JBCHEPHARMBSE : 506943ISIN CODE : INE572A01036Industry : Pharmaceuticals & DrugsHouse : Private

BSE1689.00-0.05 (0 %)

PREV CLOSE ( ) 1689.05

OPEN PRICE ( ) 1699.25

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 9924

TODAY'S LOW / HIGH ( )1685.00 1703.00

52 WK LOW / HIGH ( )1303 2029

NSE1689.101.5 (+0.09 %)

PREV CLOSE( ) 1687.60

OPEN PRICE ( ) 1696.00

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 1689.10 (8)

VOLUME 171615

TODAY'S LOW / HIGH( ) 1683.30 1703.50

52 WK LOW / HIGH ( )1385.75 2030

Chairman	Arun Duggal
Company Secretary	Sandeep Phadnis
Non Executive Director	Gaurav Trehan Prashant Kumar Akshay Tanna
Non Executive Independent Director	Ashwani Kumar Puri Sumit Bose Padmini Khare Kaicker
Whole Time Director	Nikhil Chopra

Incorporation Year : 18-12 1976

Registered Office :

Address : Neelam Centre, ' B 'wing,4th Floor, Hind Cycle Road,Worli Mumbai,
Maharashtra-400030 .

Phone : 022- 2482 2222

Industry : Pharmaceuticals & Drugs

Listing : BSE,NSE